CKCarmen Klinger

Carmen Klinger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carmen Klinger has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Benchmarking of national policies for the prevention of noncommunicable diseases: A Scoping Review

    by Eva Seyfarth, Carmen Klinger, Peter von Philipsborn

    IntroductionEach year, approximately 18 million people die prematurely from non-communicable diseases (NCDs) worldwide, many of which could be prevented through effective policies targeting modifiable risk factors. Despite strong evidence supporting the effectiveness of policies, major gaps remain in their adoption and implementation. Benchmarking national policies against international standards helps identify implementation gaps and opportunities for improvement. This study systematically reviewed existing benchmarking initiatives assessing and comparing national policies to reduce modifiable risk factors for NCDs.MethodsWe conducted a scoping review in accordance with the recommendations by the Joanna Briggs Institute and the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist. We applied a multi-stage search strategy, including a citation search based on literature known to the authors and identified through expert consultation (April-June 2025), a complementing AI-assisted search (July 2025), and a targeted search via PubMed (February 2026).ResultsA total of 243 full texts were screened, and 89 reports representing 16 benchmarking initiatives were included. Six initiatives assessed strategies to reduce harmful alcohol use, while three initiatives each focused on tobacco use, unhealthy diets, and physical inactivity. Only the World Health Organization’s NCD Progress Monitor addressed all four major risk factors. It comprises eleven indicators and is based on government self-reports supplemented by data from the World Health Organization. None of the identified initiatives enabled a comprehensive benchmarking and ranking of national strategies across all four major NCD risk factors based on objective data.ConclusionsThis scoping review provides a more nuanced understanding of current benchmarking efforts in NCD prevention and serves as a foundation for the development of a comprehensive, overarching NCD prevention index.

  • Open Access

    Recommendations for the food industry to address undernutrition and micronutrient deficiencies: a systematic review

    by Carmen Klinger, Elochukwu C. Okanmelu, Nicole Holliday, Anna Leibinger, Olufunke Alaba, Eva A. Rehfuess, Peter Delobelle, Estelle V. Lambert, Peter von Philipsborn

  • Open Access

    School food environment interventions for health and sustainability

    by Anna Leibinger, Nicole Holliday, Carmen Klinger, Xiao Tan, Laura Busert-Sebela, Lukas Schwingshackl, Eva Rehfuess, Solange Durao, Peter von Philipsborn

    To assess the effects of interventions that change the school food environment on health, nutritional, and educational outcomes in children aged 2 to 19 years, as well as on sustainability outcomes (food waste and greenhouse gas emissions). To examine how the effectiveness of school food environment interventions varies by schooling level, income level of the country, presence of co‐interventions, socioeconomic status, sex/gender, and rurality.


  • Open Access

    Commercial determinants of health—a scoping review of research ‘made in Germany’

    by Kerstin Sell, Stefanie Nigg, Anna Leibinger, Stephan Voss, Carmen Klinger, Eva Rehfuess

    Commercial products such as tobacco, alcohol, ultra-processed food and fossil fuels drive the global burden of non-communicable diseases (NCDs) and the escalating climate crisis. The concept ‘commercial determinants of health’ (CDOH) offers a framework for understanding the ways in which commercial actors, processes, and products influence health. With most CDOH research originating from Anglo-Saxon countries, we sought to map Germany’s CDOH research landscape and related scientific discourse. We conducted a scoping review according to a pre-registered protocol. Records were identified through systematic searches in Medline, Embase, Web of Science, and Google Scholar, last updated 6 December 2024, and by searching seminal CDOH literature. We included peer-reviewed articles (co-)authored by researchers affiliated with German institutions, which examined the public health effects of corporate sector practices; results were presented in an evidence map. We included 136 articles, comprising 64 original research articles (47.1%), 36 overview type articles (26.5%), and 17 opinion pieces (12.5%). Fifteen mentioned the ‘commercial determinants of health’ (11.0%). Research activities focused on the tobacco, alcohol, food, and pharmaceutical industries; articles were primarily concerned with political, scientific, marketing, and reputational management practices. A supplementary social network analysis showed fragmented authorship networks. CDOH are key upstream determinants to consider in the prevention of NCDs. Germany faces a substantial and growing burden of disease from NCDs but the country’s research on the CDOH is limited. We suggest that researchers embrace the scholarship on CDOH, and that practitioners harness relevant insights in addressing the commercially driven NCD burden.


  • Open Access

    Tool for assessing food industry commitments and practices to address the double burden of malnutrition: a Delphi study

    by Carmen Klinger, Elochukwu C. Okanmelu, Peter Delobelle, Melissa A. Theurich, Daniela Rincón Camargo, Kurt Gedrich, Nicole Holliday, Eva A. Rehfuess, Olufunke Alaba, Zandile Mchiza, et al.

    Background: Many low- and middle-income countries face a double burden of malnutrition, i.e., a co-occurrence of undernutrition with overweight, obesity, or other diet-related noncommunicable diseases. In an increasingly connected global food system, multinational and domestic food industry actors – through their commercial practices and corporate political activity – both contribute to the double burden of malnutrition and hold potential to address it. Systematic monitoring of relevant industry commitments and practices may help to hold industry accountable and foster constructive engagement. The Business Impact Assessment - Obesity and population-level nutrition (BIA-Obesity) tool has been developed to assess and benchmark food companies’ commitments and practices related to obesity and support for healthy diets at a national level. Methods: To enable the application of BIA-Obesity for countries facing a double burden of malnutrition, this study aimed to identify and select relevant best practice indicators for assessing food company commitments and practices regarding the double burden of malnutrition, with a focus on indicators not currently captured by the BIA-Obesity tool. A three-round Delphi study was conducted between April and October 2024, involving an international panel of experts. Results: From 52 invited experts, 30 contributed to our expert panel (response rate 58%). Based on a systematic review, 16 best practice indicators addressing the double burden of malnutrition were proposed. Consensus (i.e., group agreement of 75% or higher) for inclusion was reached for 8 indicators covering the production, distribution and marketing of (i) breastmilk substitutes and (ii) complementary foods, (iii) breastfeeding support and (iv) parental leave for employees, (v) food fortification, (vi) use of traditional foods, (vii) use of discounts and donations, and (viii) healthy diets at work. One additional indicator on corporate strategy was included as an overarching indicator. Conclusions: Food industry action may complement other efforts to address the double burden of malnutrition, such as public policies and investments. Tools like the extended BIA-Obesity framework can be used for a systematic monitoring of relevant industry commitments and practices and may help to disseminate and establish favourable industry practices as part of broader efforts to address the double burden of malnutrition in low- and middle-income countries. Clinical trial number: Not applicable.

  • Early and young child feeding in South Africa: expert assessment of public policy using food-EPI

    by Peter Delobelle, Nicole Holliday, Carmen Klinger, Zandile June-Rose Mchiza, Peter Von Philipsborn, Karin Geffert, Olufunke Alaba

  • Open Access

    Framing Food Waste: development and evaluation of a science communication format at the workplace

    by Stefanie Nigg, Rebecca Kandut, Julia Serong, Monica Déchène, Kateřina Veselá, Carmen Klinger

    The mitigation of the climate crisis demands effective communication strategies. Transforming food systems plays a key role in climate protection, not only by changing eating habits, but also by preventing food waste. While workplaces are commonly used for health promotion activities, they are a rare setting for science communication. This practice insight targets individual food waste reduction through a workshop at the workplace, including a lunch from rescued food, documentary screening, discussion, and expert presentation. It aimed to enhance participants’ self-efficacy and intention to reduce food waste. The effectiveness of the screening was tested experimentally by evaluating the effects of positive and negative framing. Exposure to negative framing was associated with higher intensity in negative affect, whereas positive framing appeared to be associated with higher self-efficacy. Furthermore, this practice insight provides strategies to foster science communication in workplaces.

  • Open Access

    Reach and public health implications of proposed new food marketing regulation in Germany: an updated analysis

    by Anna Leibinger, Nicole Holliday, Oliver Huizinga, Carmen Klinger, Elochukwu Okanmelu, Karin Geffert, Eva Rehfuess, Peter von Philipsborn

    Advertising for unhealthy foods adversely affects children’s food preferences and intake. The German government published plans to restrict such advertising in February 2023 and has revised them several times since. We assess the reach of the current draft from June 2023, and discuss its public health implications. We show that across 22 product categories covered by the current draft law, the median share of products permitted for marketing to children stands at 55%, with an interquartile range of 11–73%. Resistance from industry groups and from within government poses hurdles and leaves the prospects of the legislation uncertain.


  • Open Access

    Application of the WHO Nutrient Profile Model to products on the German market: Implications for proposed new food marketing legislation in Germany

    by Nicole Holliday, Anna Leibinger, Oliver Huizinga, Carmen Klinger, Elochukwu Okanmelu, Karin Geffert, Eva Rehfuess, Peter von Philipsborn

    Background Exposure to marketing for foods high in sugar, salt, and fat is considered a key risk factor for childhood obesity. To support efforts to limit such marketing, the World Health Organization Regional Office for Europe has developed a nutrient profile model (WHO NPM). Germany’s Federal Ministry of Food and Agriculture plans to use this model in proposed new legislation on food marketing directed towards children, but the model has not yet been tested on products on the German market. Against this backdrop, the present paper aims to assess the feasibility and implications of implementing the WHO NPM in Germany. Methods We applied the WHO NPM to a random sample of 660 food and beverage products across 22 product categories on the German market drawn from Open Food Facts, a publicly available product database. We calculated the share of products permitted for marketing to children based on the WHO NPM’s nutrient and ingredient criteria, both under current market conditions and for several hypothetical reformulation scenarios. We also assessed effects of adaptations to and practical challenges in applying the WHO NPM. Results The median share of products permitted for marketing to children across the model’s 22 product categories was 20% (interquartile range (IQR) 3-59%) and increased to 38% (IQR 11-73%) with model adaptations for fruit juice and milk proposed by Germany’s Federal Ministry of Food and Agriculture. With targeted reformulation (assuming a 30% reduction in fat, sugar, sodium and/or energy) the share of products permitted for marketing to children increased substantially (defined as a relative increase by at least 50%) in several product categories (including bread, processed meat, yogurt and cream, ready-made and convenience foods, and savoury plant-based foods), but changed less in the remaining categories. Practical challenges in applying the model included the ascertainment of the trans-fatty acid content of products, and the classification of products not required to carry nutrient declarations, such as fresh meats, fish, and similar products. Discussion The application of the WHO NPM to a random sample of food and beverage products on the German market was found to be feasible. Its use in the proposed new legislation on food marketing in Germany seems likely to serve its intended public health objective of limiting marketing in a targeted manner specifically for less healthy products. It seems plausible that it may incentivise reformulation in some product categories. Practical challenges in applying the model could be addressed with appropriate adaptations and procedural provisions.


  • Open Access

    Mental Health Impact of Early Stages of the COVID-19 Pandemic on Individuals with Pre-Existing Mental Disorders: A Systematic Review of Longitudinal Research

    by Angela M. Kunzler, Saskia Lindner, Nikolaus Röthke, Sarah K. Schäfer, Maria-Inti Metzendorf, Alexandra Sachkova, Roxana Müller-Eberstein, Carmen Klinger, Jacob Burns, Michaela Coenen, et al.

    In view of disease-related threats, containment measures, and disrupted healthcare, individuals with pre-existing mental illness might be vulnerable to adverse effects of the COVID-19 pandemic. Previous reviews indicated increased mental distress, with limited information on peri-pandemic changes. In this systematic review, we aimed to identify longitudinal research investigating pre- to peri-pandemic and/or peri-pandemic changes of mental health in patients, focusing on the early phase and considering specific diagnoses. PsycINFO, Web of Science, the WHO Global literature on coronavirus disease database, and the Cochrane COVID-19 Study Register weresearched through 31 May 2021. Studies were synthesized using vote counting based on effect direction. We included 40 studies mostly from Western, high-income countries. Findings were heterogeneous, with improving and deteriorating mental health observed compared to pre-pandemic data, partly depending on underlying diagnoses. For peri-pandemic changes, evidence was limited, with some suggestion of recovery of mental distress. Study quality was heterogeneous; only few studies investigated potential moderators (e.g., chronicity of mental illness). Mental health effects on people with pre-existing conditions are heterogeneous within and across diagnoses for pre- to peri-pandemic and peri-pandemic comparisons. To improve mental health services amid future global crises, forthcoming research should understand medium- and long-term effects, controlling for containment measures.